A
Achieve Life Sciences, Inc. (ACHV)
NCM – Real vaqt narxi. Valyuta: USD
6.02
+0.32 (5.61%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
5.94
-0.08 (-1.33%)
Bozordan keyin: Jun 26, 2026, 7:56 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
6.02
+0.32 (5.61%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
5.94
-0.08 (-1.33%)
Bozordan keyin: Jun 26, 2026, 7:56 PM EDT
Achieve Life Sciences, Inc., kechki bosqichdagi farmatsevtika kompaniyasi bo'lib, Kanadada, Qo'shma Shtatlarda va Buyuk Britaniyada nikotin mustaqilligi uchun sitiziniklinni ishlab chiqadi va tijoratlashtiradi. Kompaniya miyadagi nikotin retseptorlari bilan o'zaro ta'sir qiladigan va nikotinni to'xtatish alomatlarining og'irligini kamaytiradigan tabiiy alkaloid bo'lgan sitiziniklinni taklif etadi. U Sopharma AD va Bristol universiteti bilan litsenziya va ta'minot shartnomalariga ega. Achieve Life Sciences, Inc., Bothell, Vashingtonda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Andrew D. Goldberg M.D. | CEO, President & Director |
| Mr. Erik Atkisson | Chief Legal Officer |
| Mr. Jerry Wan | VP of Finance & Principal Accounting Officer |
| Mr. Mark Zappia | Senior Vice President of Commercial |
| Mr. Mark K. Oki CPA | Chief Financial Officer |
| Ms. Nicole P. Jones | Vice President of Strategic Communications & Stakeholder Relations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-08 | DEF 14A | achv-20260604.htm |
| 2026-06-08 | ARS | proxy_2026_ars.pdf |
| 2026-06-02 | 8-K | achv-20260529.htm |
| 2026-05-29 | PRE 14A | achv-20260529.htm |
| 2026-05-12 | S-8 | achv-20260512.htm |
| 2026-05-12 | S-3 | achv-20260512.htm |
| 2026-05-12 | 8-K | d854692d8k.htm |
| 2026-04-30 | 10-K/A | achv-20251231.htm |
| 2026-04-16 | S-8 | achv-20260416.htm |
| 2026-04-16 | 8-K | achv-20260415.htm |